Article Details

NIH Develops Robust SARS-CoV-2 Serology ELISAs from Serum and Dried Blood Microsamples

Retrieved on: 2021-01-04 21:58:58

Tags for this article:

Click the tags to see associated articles and topics

NIH Develops Robust SARS-CoV-2 Serology ELISAs from Serum and Dried Blood Microsamples. View article details on hiswai:

Excerpt

... using Mitra® microsampling devices with VAMS technology from Neoteryx gives ... Neoteryx LLC, a medical device company in Torrance, California, delivers ... Its Mitra Microsampler, an FDA-listed Class 1 exempt medical device, ...

Article found on: www.heraldmailmedia.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up